Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway
Biochemical Pharmacology · 2023
DOI: 10.1016/j.bcp.2023.115503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Pharmacology, 2023. Verfasst von Huihui Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha, China; Clinical Immunology Research Center of Central…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Glucocorticoids. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Xiangya Hospital, Central South University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Conventional glucocorticoid (GC) treatment has a long-term influence on T-cell immunity, resulting in an increased risk of opportunistic infection after drug withdrawal. The underlying mechanisms remain ambiguous. This study demonstrated that long-term GC treatment induced persistent lymphopenia in patients with primary glomerular disease. GCs continuously suppressed the proportion of CD4+ T cells even after the daily dose was tapered down to the physiologic equivalences, leading to a significant decline of the CD4/CD8 ratio. Meanwhile, GCs impaired CD4+ T cell biology, leading to enhanced apoptotic cell death, reduced proliferative capacity, downregulated pro-inflammatory genes, and upregulated immunoregulatory genes. Specifically, GCs altered FOXP3 expression pattern in CD4+ T cells and favored their acquisition of an active T regulatory (Treg) cell phenotype with enhanced IL-10 production upon stimulation. Mechanistically, GCs tampered with the transcriptional regulation of mechanistic target of rapamycin complex 1 (mTORC1) pathway, resulting in an inhibitory impact on the signaling activity. Targeting mTORC1 signaling by siRNAs could sufficiently modify the viability of GC-exposed CD4+ T cells. By high-throughput sequencing of genome-wide DNA methylation and mRNA, we further uncovered a causal relationship between the altered DNA methylation level and transcription activity in a subset of mTORC1 pathway genes in long-term GC exposure. Taken together, this study reveals a novel regulation of mTORC1 signaling, which might dominate the long-term influence of GC on CD4+ T cell biology in a dose-independent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha, China; Clinical Immunology Research Center of Central South University, Changsha, China.
- Department of Pharmacy, the Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Ophthalmology, the Second Xiangya Hospital of Central South University, Changsha, China.
- Department of Nephrology, the Second Xiangya Hospital of Central South University, Changsha, China; Hunan Key Laboratory of Kidney Disease and Blood Purification, the Second Xiangya Hospital of Central South University,…
- Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University and Charlie Norwood Veterans Affairs Medical Center, Augusta, GA, USA.
- Clinical Immunology Research Center of Central South University, Changsha, China; Department of Nephrology, the Second Xiangya Hospital of Central South University, Changsha, China; Hunan Key Laboratory of Kidney Diseas…
Förderung
- Xiangya Hospital, Central South University
- National Natural Science Foundation of China
Zitieren
APA
Chen, H., Tan, C., Wang, Z., Zha, J., Liu, H., Dong, Z., & Chen, G. (2023). Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2023.115503
Vancouver
Chen H, Tan C, Wang Z, Zha J, Liu H, Dong Z, et al. Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway. Biochemical Pharmacology. 2023. doi:10.1016/j.bcp.2023.115503
BibTeX
@article{Chen2023,
author = {Chen, Huihui and Tan, Chongqing and Wang, Zhiruo and Zha, Jie and Liu, Hong and Dong, Zheng and Chen, Guochun},
title = {Long-term glucocorticoid exposure persistently impairs CD4+ T cell biology by epigenetically modulating the mTORC1 pathway},
journal = {Biochemical Pharmacology},
year = {2023},
doi = {10.1016/j.bcp.2023.115503}
}
EUVIMED